4.7 Review

The endocannabinoid system as a target for the treatment of neurodegenerative disease

期刊

BRITISH JOURNAL OF PHARMACOLOGY
卷 160, 期 3, 页码 480-498

出版社

WILEY
DOI: 10.1111/j.1476-5381.2010.00735.x

关键词

cannabinoid; endocannabinoid; anandamide; 2-arachidonoylglycerol; neuroprotective; anti-inflammatory

资金

  1. NIDA NIH HHS [P50 DA005274, R01 DA009978] Funding Source: Medline
  2. NINDS NIH HHS [R21 NS041639] Funding Source: Medline
  3. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS041639] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005274, R01DA009978] Funding Source: NIH RePORTER

向作者/读者索取更多资源

This article is part of a themed issue on Cannabinoids. To view the editorial for this themed issue visit http://dx.doi.org/10.1111/j.1476-5381.2010.00831.x.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据